Quinism Foundation Director to Speak at Ottawa Mefloquine Conference
Dr. Remington Nevin, executive and medical director of The Quinism Foundation, will speak at the 10th Annual Mefloquine Conference in Ottawa on October 3. He will lead an educational session on the drug's effects.

Dr. Remington Nevin, executive and medical director of The Quinism Foundation, is scheduled to speak at the 10th Annual Mefloquine Conference in Ottawa, Ontario, on Saturday, October 3, 2026. The conference, held at the Royal Canadian Legion's Montgomery Branch, aims to educate attendees about the health effects associated with mefloquine use, a condition known as quinism or chronic quinoline encephalopathy.
Dr. Nevin's educational session will take place from 1:00 PM to 4:00 PM Eastern Daylight Time. The session will address the neurological symptoms that can arise from mefloquine exposure, which may be mistaken for post-traumatic stress disorder or traumatic brain injury, particularly among veterans. He plans to answer questions and share information about the foundation's research and resources.
The conference continues on Sunday, October 4, with a focus on public awareness and advocacy on Parliament Hill. The weekend's activities are intended to raise awareness about the potential long-term effects of mefloquine and to support those affected by quinism. The Quinism Foundation is a non-profit organization dedicated to promoting research and education on the condition.
Dr. Nevin, who is board-certified in occupational and preventive medicine and is a former U.S. Army epidemiologist, emphasizes the importance of education for both patients and healthcare professionals. He believes that sharing information is crucial for understanding the causes of symptoms and for identifying cases that may be related to mefloquine exposure.